Business · 16/08/2018Updated: 10/17/2026 · 1 min read
FDA Requests Public Comment on Proposed Survey of Investigational New Drug Sponsors
Summary
The Food and Drug Administration is seeking public input on a proposed survey of sponsors of investigational new drugs to assess their communication practices with FDA review staff, as required by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →